Originally developed to treat Type 2 diabetes, GLP-1 medications are now widely used for weight management
Gallbladder and Biliary Tract Diseases In addition to obesity, rapid and excessive weight loss is known to reduce gallbladder motility, alter bile composition, and thereby predispose individuals to gallstone formation
This helps your body get used to the medication and reduces side effects
Understanding its effects enables you to navigate treatment confidently
In parallel, educational hubs and FAQs should explain how to interpret RTP, variance, and house edges, empowering users to set expectations and make informed decisions
GLP-3 (Reta) is not currently named on the WADA 2026 Prohibited List